CIB vs. NMR: A Head-to-Head Stock Comparison

Updated on August 19, 2025

Here’s a clear look at CIB and NMR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Both CIB and NMR are American Depositary Receipts (ADRs). This provides U.S. investors with straightforward access to investing in these foreign-listed companies.

Symbol	CIB	NMR
Company Name	Grupo Cibest S.A.	Nomura Holdings, Inc.
Country	Colombia	Japan
GICS Sector	Financials	Financials
GICS Industry	Banks	Capital Markets
Market Capitalization	12.52 billion USD	21.27 billion USD
Exchange	NYSE	NYSE
Listing Date	July 26, 1995	December 17, 2001
Security Type	ADR	ADR

Historical Performance

This chart compares the performance of CIB and NMR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CIB vs. NMR: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	CIB	NMR
5-Day Price Return	0.67%	6.34%
13-Week Price Return	6.71%	21.91%
26-Week Price Return	2.79%	7.60%
52-Week Price Return	-27.92%	23.08%
Month-to-Date Return	2.90%	6.02%
Year-to-Date Return	-28.94%	14.41%
10-Day Avg. Volume	0.05M	12.97M
3-Month Avg. Volume	3.15M	13.51M
3-Month Volatility	--	21.77%
Beta	1.34	1.55

Profitability

Return on Equity (TTM)

CIB

15.44%

Banks Industry

Max: 26.37%
Q3: 15.92%
Median: 12.25%
Q1: 8.69%
Min: 0.15%

CIB’s Return on Equity of 15.44% is on par with the norm for the Banks industry, indicating its profitability relative to shareholder equity is typical for the sector.

NMR

9.87%

Capital Markets Industry

Max: 38.97%
Q3: 21.61%
Median: 13.77%
Q1: 8.31%
Min: -4.25%

NMR’s Return on Equity of 9.87% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

CIB vs. NMR: A comparison of their Return on Equity (TTM) against their respective Banks and Capital Markets industry benchmarks.

Net Profit Margin (TTM)

CIB

20.33%

Banks Industry

Max: 54.20%
Q3: 35.70%
Median: 28.97%
Q1: 22.53%
Min: 6.98%

Falling into the lower quartile for the Banks industry, CIB’s Net Profit Margin of 20.33% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

NMR

7.19%

Capital Markets Industry

Max: 66.67%
Q3: 35.11%
Median: 23.49%
Q1: 13.63%
Min: -15.18%

Falling into the lower quartile for the Capital Markets industry, NMR’s Net Profit Margin of 7.19% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

CIB vs. NMR: A comparison of their Net Profit Margin (TTM) against their respective Banks and Capital Markets industry benchmarks.

Operating Profit Margin (TTM)

CIB

25.93%

Banks Industry

Max: 63.35%
Q3: 44.59%
Median: 37.24%
Q1: 28.25%
Min: 13.37%

CIB’s Operating Profit Margin of 25.93% is in the lower quartile for the Banks industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

NMR

9.96%

Capital Markets Industry

Max: 86.40%
Q3: 46.46%
Median: 32.80%
Q1: 18.32%
Min: -21.87%

NMR’s Operating Profit Margin of 9.96% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

CIB vs. NMR: A comparison of their Operating Profit Margin (TTM) against their respective Banks and Capital Markets industry benchmarks.

Profitability at a Glance

Symbol	CIB	NMR
Return on Equity (TTM)	15.44%	9.87%
Return on Assets (TTM)	1.76%	0.58%
Net Profit Margin (TTM)	20.33%	7.19%
Operating Profit Margin (TTM)	25.93%	9.96%
Gross Profit Margin (TTM)	--	39.95%

Financial Strength

Current Ratio (MRQ)

CIB

Banks Industry

Max: --
Q3: --
Median: --
Q1: --
Min: --

For the Banks industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

NMR

0.23

Capital Markets Industry

Max: 3.76
Q3: 1.89
Median: 1.01
Q1: 0.54
Min: -0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

CIB vs. NMR: A comparison of their Current Ratio (MRQ) against their respective Banks and Capital Markets industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CIB

0.65

Banks Industry

Max: 4.75
Q3: 2.62
Median: 1.02
Q1: 0.39
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Banks industry.

NMR

10.44

Capital Markets Industry

Max: 6.62
Q3: 2.84
Median: 1.02
Q1: 0.32
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

CIB vs. NMR: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Banks and Capital Markets industry benchmarks.

Interest Coverage Ratio (TTM)

CIB

Banks Industry

Max: --
Q3: --
Median: --
Q1: --
Min: --

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Banks industry.

NMR

Capital Markets Industry

Max: 126.03
Q3: 60.98
Median: 11.77
Q1: 4.95
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

CIB vs. NMR: A comparison of their Interest Coverage Ratio (TTM) against their respective Banks and Capital Markets industry benchmarks.

Financial Strength at a Glance

Symbol	CIB	NMR
Current Ratio (MRQ)	--	0.23
Quick Ratio (MRQ)	--	0.23
Debt-to-Equity Ratio (MRQ)	0.65	10.44
Interest Coverage Ratio (TTM)	--	--

Growth

Revenue Growth

CIB vs. NMR: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CIB vs. NMR: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CIB

12.09%

Banks Industry

Max: 10.27%
Q3: 5.83%
Median: 3.81%
Q1: 2.50%
Min: 0.00%

CIB’s Dividend Yield of 12.09% is exceptionally high, placing it well above the typical range for the Banks industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.

NMR

3.64%

Capital Markets Industry

Max: 10.26%
Q3: 4.86%
Median: 2.78%
Q1: 1.22%
Min: 0.00%

NMR’s Dividend Yield of 3.64% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

CIB vs. NMR: A comparison of their Dividend Yield (TTM) against their respective Banks and Capital Markets industry benchmarks.

Dividend Payout Ratio (TTM)

CIB

53.59%

Banks Industry

Max: 147.07%
Q3: 80.55%
Median: 54.40%
Q1: 35.71%
Min: 0.00%

CIB’s Dividend Payout Ratio of 53.59% is within the typical range for the Banks industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

NMR

66.06%

Capital Markets Industry

Max: 200.72%
Q3: 101.92%
Median: 57.97%
Q1: 32.36%
Min: 0.00%

NMR’s Dividend Payout Ratio of 66.06% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CIB vs. NMR: A comparison of their Dividend Payout Ratio (TTM) against their respective Banks and Capital Markets industry benchmarks.

Dividend at a Glance

Symbol	CIB	NMR
Dividend Yield (TTM)	12.09%	3.64%
Dividend Payout Ratio (TTM)	53.59%	66.06%

Valuation

Price-to-Earnings Ratio (TTM)

CIB

4.43

Banks Industry

Max: 20.05
Q3: 12.65
Median: 10.21
Q1: 7.54
Min: 2.74

In the lower quartile for the Banks industry, CIB’s P/E Ratio of 4.43 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

NMR

9.09

Capital Markets Industry

Max: 58.89
Q3: 31.00
Median: 18.54
Q1: 12.09
Min: 5.24

In the lower quartile for the Capital Markets industry, NMR’s P/E Ratio of 9.09 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

CIB vs. NMR: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Banks and Capital Markets industry benchmarks.

Price-to-Sales Ratio (TTM)

CIB

0.89

Banks Industry

Max: 5.06
Q3: 2.98
Median: 2.24
Q1: 1.59
Min: 0.45

The P/S Ratio is often not a primary valuation tool in the Banks industry.

NMR

0.65

Capital Markets Industry

Max: 14.49
Q3: 7.41
Median: 4.68
Q1: 2.25
Min: 0.04

In the lower quartile for the Capital Markets industry, NMR’s P/S Ratio of 0.65 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

CIB vs. NMR: A comparison of their Price-to-Sales Ratio (TTM) against their respective Banks and Capital Markets industry benchmarks.

Price-to-Book Ratio (MRQ)

CIB

1.05

Banks Industry

Max: 2.18
Q3: 1.36
Median: 1.09
Q1: 0.81
Min: 0.20

CIB’s P/B Ratio of 1.05 is within the conventional range for the Banks industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

NMR

0.83

Capital Markets Industry

Max: 9.48
Q3: 4.94
Median: 2.42
Q1: 1.21
Min: 0.38

NMR’s P/B Ratio of 0.83 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

CIB vs. NMR: A comparison of their Price-to-Book Ratio (MRQ) against their respective Banks and Capital Markets industry benchmarks.

Valuation at a Glance

Symbol	CIB	NMR
Price-to-Earnings Ratio (TTM)	4.43	9.09
Price-to-Sales Ratio (TTM)	0.89	0.65
Price-to-Book Ratio (MRQ)	1.05	0.83
Price-to-Free Cash Flow Ratio (TTM)	1.86	3.24